Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV12 Non-Inferiority in Healthy Children
NCT05721456Phase 3Unknown
- Start
- Aug 2023
- Primary completion
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of 12-valent pneumococcal conjugate vaccine in pneumococcal infection. Status: unknown.
02
Drugs
12-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT05721456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05721456.